A Family With Factor VII Deficiency: A Possible Autosomal Dominant Transmission

Zheng Song, Sebastián García, Thiagarajan Nandhagopal, Sun KimCureus 2025 · DOI

TL;DR

This case report challenges the traditional classification of Factor VII (FVII) deficiency as a strictly autosomal recessive disorder. By documenting a family where a mother and all three of her children exhibit varying degrees of FVII deficiency—despite the father having normal levels—the authors suggest a possible autosomal dominant transmission or a dominant-negative genetic effect.

What Problem Does This Paper Address?

Coagulation Factor VII is a vital component of the extrinsic pathway of the blood clotting cascade. While deficiencies in Factors VIII and IX (Hemophilia A and B) are well-known X-linked disorders, FVII deficiency is rare (occurring in roughly 1 in 500,000 people) and has historically been categorized as autosomal recessive. Under this model, "carriers" (heterozygotes) should be asymptomatic with relatively normal factor levels.

However, clinical reality often contradicts this neat classification. Some heterozygous individuals experience severe bleeding, while some homozygous individuals remain asymptomatic. This paper investigates a specific clinical case of severe abnormal uterine bleeding (AUB) in an adolescent girl, which led to a family-wide screening that revealed an inheritance pattern inconsistent with the standard recessive model.

Methods

The researchers conducted a clinical case study and a subsequent pedigree analysis of a single family. The primary diagnostic tools were standard hematological laboratory assays:

  • Prothrombin Time (PT) and International Normalized Ratio (INR): Used to assess the extrinsic pathway.
  • Activated Partial Thromboplastin Time (aPTT): Used to assess the intrinsic pathway.
  • Factor VII Activity Assay: A specialized test to quantify the functional activity of FVII in the blood (normal range: 60–150%).
  • Pedigree Mapping: The team tracked these laboratory values across two generations (parents and three children) to visualize the transmission of the deficiency.

Datasets

As a clinical case report, this paper does not utilize large-scale datasets or machine learning benchmarks. The "data" consists of the clinical history and laboratory results of five family members. The authors also performed a literature review via PubMed (up to October 2024) to contextualize their findings within existing reports of FVII deficiency and AUB.

Key Insights and Ideas

  • AUB as a Red Flag: In adolescent patients, severe menorrhagia (heavy menstrual bleeding) that leads to hemodynamic instability can be the first clinical presentation of a rare bleeding disorder, even in the absence of a known family history.
  • Inheritance Anomalies: The most striking insight is the pedigree: the mother (55% activity) and all three children (Son: 40%, Daughter 1: <1%, Daughter 2: <1%) showed reduced FVII activity, while the father remained within the normal range (66%).
  • The Dominant-Negative Hypothesis: The authors propose that a mutation in one F7 gene allele might produce a defective protein that interferes with the function of the protein produced by the healthy allele. This "dominant-negative" effect is documented in Factor XI deficiency (Hemophilia C) but is not yet standard for Factor VII.
  • Phenotype-Genotype Mismatch: The paper reinforces that serum factor activity levels do not always correlate perfectly with clinical symptoms. The mother and son were asymptomatic despite reduced levels, while both daughters suffered life-threatening bleeding episodes with levels <1%.

Key Results

  • Clinical Success: The 11-year-old patient, who presented with a hemoglobin level of 5.8 g/dL (severe anemia) and 18 days of bleeding, was successfully stabilized using recombinant human factor VII (rFVIIa) after standard hormonal treatments failed.
  • Pedigree Findings:
    • Daughters 1 & 2: Both exhibited severe deficiency (<1% activity) and severe clinical symptoms.
  • Son: Exhibited moderate deficiency (40% activity) but remained asymptomatic.
  • Mother: Exhibited mild deficiency (55% activity) and was asymptomatic.
  • Father: Remained within the reference range (66% activity).
  • Transmission Pattern: Because the mother passed the trait to 100% of her offspring while the father tested normal, the case strongly suggests a non-recessive mode of transmission within this specific lineage.

Limitations and Future Work

The primary limitation of this study is the absence of genetic sequencing. While the biochemical data (factor activity levels) strongly suggest a specific inheritance pattern, the family declined genetic testing. Without DNA analysis of the F7 gene, the authors cannot confirm whether the daughters are compound heterozygotes (inheriting different mutations from each parent) or if a single dominant-negative mutation is at play.

Future research should focus on genetic characterization of similar families to identify specific F7 mutations that exhibit dominant inheritance. This could eventually lead to more accurate genetic counseling and personalized management strategies for patients with rare coagulation deficiencies.

Summary updated

Abstract

Coagulation factor VII plays a crucial role in the extrinsic pathway of the coagulation cascade. Deficiency of coagulation factors, including factor VII, is a rare but recognized cause of abnormal uterine bleeding (AUB) in women. This case report presents an 11-year-old previously healthy girl who arrived at the emergency department with 18 days of heavy menstrual bleeding and hemodynamic instability due to severe anemia. Laboratory evaluation revealed prolonged prothrombin time (PT/INR) with a normal partial thromboplastin time (PTT). A factor VII activity assay confirmed a severely decreased serum factor VII level. Bleeding was successfully managed with recombinant human factor VII. Further family screening showed reduced factor VII activity in the patient's mother and three siblings, while the father's levels were normal, suggesting a possible dominant inheritance pattern. However, genetic testing is required to confirm this hypothesis.
BibTeX
@inproceedings{song2025family,
  author = {Zheng Song and Sebastián García and Thiagarajan Nandhagopal and Sun Kim},
  title = {{A Family With Factor VII Deficiency: A Possible Autosomal Dominant Transmission}},
  booktitle = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.82526},
}
Figure